Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
2013
Accelerated telomere shortening in response to life stress
2004 StandoutNobel
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB
2015
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
Metastasis: from dissemination to organ-specific colonization
2009 Standout
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
1999
Transcriptional Regulation by Nrf2
2017 Standout
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
2009
Immunoediting of Cancers May Lead to Epithelial to Mesenchymal Transition
2006
A genetic method specifically delineates Th1-type Treg cells and their roles in tumor immunity
2023 StandoutNobel
Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression
1999
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors
2007
Therapeutic Immunity by Adoptive Tumor-primed CD4+ T-cell Transfer in Combination With In Vivo GITR Ligation
2009 StandoutNobel
Peptide Vaccination Breaks Tolerance to HER-2/ neu by Generating Vaccine-Specific FasL+ CD4+ T Cells: First Evidence for Intratumor Apoptotic Regulatory T Cells
2010
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Regulatory T Cells in Cancer
2010
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Tumor immunoediting and immunosculpting pathways to cancer progression
2007
Stromal cells in tumor microenvironment and breast cancer
2012
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
2008
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell—The Unit of Selection
2003
Attenuated T Cell Responses to a High-Potency Ligand In Vivo
2010 StandoutNobel
The biochemistry and medical significance of the flavonoids
2002 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
How regulatory T cells work
2008 Standout
p53 in health and disease
2007 Standout
CD4 +CD25 + Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients
2007
Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals
1998
Telomeres, stem cells, senescence, and cancer
2004
Tumor Microenvironment and Immune Escape
2007
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Regulatory T cells in tumor immunity
2010 StandoutNobel
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
2016
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
2018
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Tregs and rethinking cancer immunotherapy
2007
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation*
1999
Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women
2008 StandoutNobel
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Hoxa11 Regulates Stromal Cell Death and Proliferation during Neonatal Uterine Development
2003 StandoutNobel
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
2007
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL− Tumors
2008
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides.
1999
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
2017 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
2010
Antioxidant properties of different cultivars of Portulaca oleracea
2006 Standout
Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia
2006
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
1998
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
2008
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
2004
Works of Jason Lukas being referenced
The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
2013 Nobel
Telomerase activity in normal and neoplastic breast.
1997
IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu-Transgenic Mice
2006
WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
1997